Literature DB >> 7936419

Receptor-mediated activation of G proteins is reduced in postmortem brains from Alzheimer's disease patients.

H Y Wang1, E Friedman.   

Abstract

The effects of Alzheimer's disease (AD) on [35S]GTP gamma S binding to G proteins was examined in postmortem cerebrocortex. Stimulation of the beta-adrenergic or muscarinic cholinergic receptors in control tissue with selective agonists resulted in increases in [35S]GTP gamma S binding to G alpha proteins in a receptor-specific fashion. The responses were markedly reduced in brain tissues from AD patients. In contrast, basal [35S]GTP gamma S binding to the G alpha proteins was relatively intact in AD brains. Immunoblot analyses reveal that levels of cerebrocortical G alpha proteins in AD are not altered. The results suggest that in AD the decrease in agonist-stimulated [35S]GTP gamma S binding to G proteins may be a result of decoupling between receptors and their associated G proteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7936419     DOI: 10.1016/0304-3940(94)90144-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Agonist-induced restoration of hippocampal neurogenesis and cognitive improvement in a model of cholinergic denervation.

Authors:  Jackalina M Van Kampen; Christopher B Eckman
Journal:  Neuropharmacology       Date:  2009-12-22       Impact factor: 5.250

2.  Insulin and adipokine signaling and their cross-regulation in postmortem human brain.

Authors:  Hoau-Yan Wang; Ana W Capuano; Amber Khan; Zhe Pei; Kuo-Chieh Lee; David A Bennett; Rexford S Ahima; Steven E Arnold; Zoe Arvanitakis
Journal:  Neurobiol Aging       Date:  2019-08-20       Impact factor: 4.673

Review 3.  The biochemistry of Alzheimer's disease.

Authors:  G J Stege; G J Bosman
Journal:  Drugs Aging       Date:  1999-06       Impact factor: 3.923

4.  Quantitative proteomic analysis of mitochondria from primary neuron cultures treated with amyloid beta peptide.

Authors:  Mark A Lovell; Shuling Xiong; William R Markesbery; Bert C Lynn
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

5.  Heterotrimeric g proteins: insights into the neurobiology of mood disorders.

Authors:  Javier González-Maeso; J Javier Meana
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

Review 6.  Disturbances in signal transduction mechanisms in Alzheimer's disease.

Authors:  C J Fowler; R F Cowburn; A Garlind; B Winblad; C O'Neill
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

Review 7.  Successful therapies for Alzheimer's disease: why so many in animal models and none in humans?

Authors:  Rafael Franco; Angel Cedazo-Minguez
Journal:  Front Pharmacol       Date:  2014-06-25       Impact factor: 5.810

8.  Characterization of dopamine D2 receptor coupling to G proteins in postmortem brain of subjects with schizophrenia.

Authors:  Iker Egusquiza; Eva Munarriz-Cuezva; Rafael Segarra; Javier González-Maeso; Luis F Callado; J Javier Meana; Rebeca Diez-Alarcia
Journal:  Pharmacol Rep       Date:  2021-07-01       Impact factor: 3.024

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.